Profound Medical (TSE:PRN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Profound Medical Corp. has successfully closed a $40.25 million public offering of common shares, with the funds aimed at boosting the commercialization of their TULSA-PRO and Sonalleve systems. The offering saw strong interest with the full exercise of the over-allotment option, highlighting investor confidence in Profound Medical’s innovative medical device technologies.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
